secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-267443
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q3 revenue $363.8M (+16% YoY), net income $1.1M; raises FY2025 adjusted EBITDA guidance to $146-152M
--------------------------------------------------------------------------------

- Revenue $363.8M vs $312.7M YoY (+16%); net income $1.1M vs net loss of $6.0M.
- Adjusted EBITDA $40.2M, up 31% YoY; margin 11.1% vs 9.8%.
- Clinician base grew 11% to 7,996; visit volumes +17% to 2.3M.
- FY2025 guidance raised: Center Margin $448-462M, Adjusted EBITDA $146-152M.
- Free cash flow positive $17.0M; cash balance $203.9M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312525267443/0001193125-25-267443-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312525267443/lfst-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-267443

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer